Biomedical Engineering Reference
In-Depth Information
34. Hashimoto T, Obata K (1991) Induction of
somatostatin by kainic acid in pyramidal and
granule cells of the rat hippocampus. Neurosci
Res 12(4):514-527
35. Manfridi A, Forloni GL, Vezzani A et al (1991)
Functional and histological consequences of
quinolinic and kainic acid-induced seizures on
hippocampal
a novel perspective for seizure control. Exp
Neurol 208(1):26-37
48. Theofilas P, Brar S, Stewart KA et al (2011)
Adenosine kinase as a target for therapeutic
antisense strategies in epilepsy. Epilepsia
52(3):589-601
49. Simonato M, Tongiorgi E, Kokaia M (2006)
Angels and demons: neurotrophic factors and
epilepsy. Trends Pharmacol Sci 27(12):631-638
50. Yoo YM, Lee CJ, Lee U et al (2006)
Neuroprotection of adenoviral-vector-medi-
ated GDNF expression against kainic-acid-
induced excitotoxicity in the rat hippocampus.
Exp Neurol 200(2):407-417
51. Kanter-Schlifke I, Georgievska B, Kirik D et al
(2007) Seizure suppression by GDNF gene
therapy in animal models of epilepsy. Mol Ther
15(6):1106-1113
52. Rao MS, Hattiangady B, Rai KS et al (2007)
Strategies for promoting anti-seizure effects of
hippocampal fetal cells grafted into the hippo-
campus of rats exhibiting chronic temporal
lobe epilepsy. Neurobiol Dis 27(2):117-132
53. Paradiso B, Marconi P, Zucchini S et al (2009)
Localized delivery of fibroblast growth fac-
tor-2 and brain-derived neurotrophic factor
reduces spontaneous seizures in an epilepsy
model. Proc Natl Acad Sci U S A
106(17):7191-7196
54. Paradiso B, Zucchini S, Su T et al (2011)
Localized overexpression of FGF-2 and BDNF
in hippocampus reduces mossy fiber sprouting
and spontaneous seizures up to 4 weeks after
pilocarpine-induced
somatostatin
neurons.
Neuroscience 41(1):127-135
36. Buckmaster PS, Otero-Corchon V, Rubinstein
M et al (2002) Heightened seizure severity in
somatostatin knockout mice. Epilepsy Res
48(1-2):43-56
37. Mazarati A, Wasterlain CG (2002)
Anticonvulsant effects of four neuropeptides in
the rat hippocampus during self-sustaining sta-
tus epilepticus. Neurosci Lett 331(2):
123-127
38. Zafar R, King MA, Carney PR (2012) Adeno
associated viral vector-mediated expression of
somatostatin in rat hippocampus suppresses
seizure development. Neurosci Lett 509(2):
87-91
39. Lee KS, Schubert P, Heinemann U (1984) The
anticonvulsive action of adenosine: a postsynap-
tic, dendritic action by a possible endogenous
anticonvulsant. Brain Res 321(1):160-164
40. Dragunow M, Goddard GV, Laverty R (1985)
Is adenosine an endogenous anticonvulsant?
Epilepsia 26(5):480-487
41. During MJ, Spencer DD (1992) Adenosine: a
potential mediator of seizure arrest and postic-
tal refractoriness. Ann Neurol 32(5):618-624
42. Fedele DE, Li T, Lan JQ et al (2006)
Adenosine A1 receptors are crucial in keeping
an epileptic focus localized. Exp Neurol
200(1):184-190
43. Huber A, Padrun V, Deglon N et al (2001)
Grafts of adenosine-releasing cells suppress sei-
zures in kindling epilepsy. Proc Natl Acad Sci
U S A 98(13):7611-7616
44. Guttinger M, Fedele D, Koch P et al (2005)
Suppression of kindled seizures by paracrine
adenosine release from stem cell-derived brain
implants. Epilepsia 46(8):1162-1169
45. Li T, Steinbeck JA, Lusardi T et al (2007)
Suppression of kindling epileptogenesis by
adenosine releasing stem cell-derived brain
implants. Brain 130(Pt 5):1276-1288
46. Guttinger M, Padrun V, Pralong WF et al
(2005) Seizure suppression and lack of ade-
nosine A1 receptor desensitization after focal
long-term delivery of adenosine by encapsu-
lated myoblasts. Exp Neurol 193(1):53-64
47. Ren G, Li T, Lan JQ et al (2007) Lentiviral
RNAi-induced downregulation of adenosine
kinase in human mesenchymal stem cell grafts:
status
epilepticus.
Epilepsia 52(3):572-578
55. Bovolenta R, Zucchini S, Paradiso B et al
(2010) Hippocampal FGF-2 and BDNF over-
expression attenuates epileptogenesis-associated
neuroinflammation and reduces spontaneous
recurrent seizures. J Neuroinflammation 7:81
56. Zhang LX, Li XL, Smith MA et al (1997)
Lipofectin-facilitated transfer of cholecystoki-
nin gene corrects behavioral abnormalities of
rats with audiogenic seizures. Neuroscience
77(1):15-22
57. Laing JM, Gober MD, Golembewski EK et al
(2006) Intranasal administration of the
growth-compromised HSV-2 vector DeltaRR
prevents kainate-induced seizures and neuro-
nal loss in rats and mice. Mol Ther
13(5):870-881
58. McLaughlin J, Roozendaal B, Dumas T et al
(2000) Sparing of neuronal function postsei-
zure with gene therapy. Proc Natl Acad Sci
U S A 97(23):12804-12809
59. Yenari MA, Fink SL, Sun GH et al (1998)
Gene therapy with HSP72 is neuroprotective
Search WWH ::
Custom Search